If these and other questions can be answered, maybe we can do a lot to optimize the tumor-killing effect of L-Arg bacteria combined with other therapeutic strategies including PD-L1 antibodies, other immunotherapy, and even targeted therapy, and make them effective against more cancer types. The gene discussed is CD274; the disease is neoplasm.